🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Dementia, Frontotemporal

Daridorexant for Alzheimer Disease Prevention NCT07213349Phase 21 site📍 Montreal Douglas Mental Health University Institute · Tests: Daridorexant 50 mg, Placebo Molecular Neuroimaging of Neuroinflammation in Neurodegenerative Dementias NCT02945774NA1 site📍 London London Health Sciences Centre Research Institute OR Lawson … · Tests: (18F)-FEPPA Neurodegenerative Diseases Progression Markers (MARKERS-NDD) NCT06596746n/a1 site📍 Cassino Casa di Cura San Raffaele Cassino · Tests: Observation Stimulating the Aging Brain Using Brain and Sensory Stimulation NCT07650188NA1 site📍 Milwaukee Medical College of Wisconsin · Tests: tACS or multisensory stimulation Retinal Hyperspectral Imaging in Neurodegenerative Diseases NCT07545473NA1 site📍 Melbourne Center for Eye Research Australia · Tests: Hyperspectral camera GENetic Fronto Temporal Dementia Initiative in Lille NCT04639622NA1 site📍 Lille University Hospital, Lille · Tests: Investigation procedures A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC) NCT07082725Phase 334 sites📍 Oakland📍 Minneapolis📍 Rochester Azafaros B.V. · Tests: Nizubaglustat, Placebo Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in Older Adults NCT06733714NA1 site📍 Rio de Janeiro Universidade Federal do Rio de Janeiro · Tests: Transcranial Alternating Current Stimulation, Digital Cognitive Training A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy NCT07498426Phase 364 sites📍 Scottsdale📍 San Francisco📍 Englewood Novartis Pharmaceuticals · Tests: NIO752, Placebo Long Term Effect of Brain Stimulation in PPA NCT07158216NA1 site📍 Madrid Hospital San Carlos, Madrid · Tests: TMS, tDCS, Sham TMS, Sham tDCS Enhancing Language Function in Aphasia NCT05443633NA1 site📍 Tucson University of Arizona · Tests: individualized speech-language training, standard language intervention The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3) NCT05885295n/a1 site📍 London Imperial College London · Tests: MRI brain, Blood tests, cognitive assessments Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease NCT04576793Phase 21 site📍 New York Columbia University · Tests: 11C-ER176, 18F-MK6240, 18F-Florbetaben, Lumbar Puncture Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative Diseases NCT07531732n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Computer-based facial expression recognition task, Computerized affective task, UCLA Structured Insight Interview, Barb… DC Longitudinal Study on Aging and Specimen Bank NCT03702907n/a1 site📍 Washington D.C. Georgetown University A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C NCT05163288Phase 314 sites📍 Rochester📍 Parkville📍 Prague IntraBio Inc · Tests: N-Acetyl-L-Leucine, Placebo National Multicentre Study of the Natural History of Acid Sphingo-myelinase Deficiency in Adults and Children NCT06985212n/a1 site📍 Paris Wladimir MAUHIN, Dr Intervention for Communication Quality of Life in Primary Progressive Aphasia NCT07219680NA1 site📍 Austin Maya Henry · Tests: Multicomponent Lexical Retrieval Cascade Training, Multicomponent Video Implemented Script Training in Aphasia Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia NCT06511752EARLY Phase 11 site📍 Austin University of Texas at Austin · Tests: Psychosocial educational, support group and implementation of strategies Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia NCT03225144n/a1 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… Cerebro Spinal Fluid Collection (CSF) NCT04844060n/a1 site📍 Strasbourg University Hospital, Strasbourg, France · Tests: Lumbar punction UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells NCT02254863Phase 11 site📍 Durham Joanne Kurtzberg, MD · Tests: DUOC-01 The Swedish BioFINDER 2 Study NCT03174938NA2 sites📍 Ängelholm📍 Malmö Skane University Hospital · Tests: Flutemetamol F18 Injection, [18F]-RO6958948, Elecsys (Roche) Abeta42, Ttau and Ptau, Lumipulse (Fujirebio) Abeta42, Tta… Genetic Frontotemporal Dementia Initiative for Neurodevelopment NCT05779813n/a1 site📍 London Western University AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980) NCT07158905Phase 16 sites📍 Boca Raton📍 Miami Lakes📍 Stuart Institute for Molecular Medicine · Tests: AV-1980R 20 µg, AV-1980R 60 µg, AV-1980R 180 µg, Placebo PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620 NCT05456503Phase 31 site📍 Philadelphia University of Pennsylvania · Tests: [18F]-PI-2620 ALS Research Collaborative NCT06885918n/a1 site📍 Watertown ALS Therapy Development Institute A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN) NCT06064890Phase 1, Phase 219 sites📍 Columbus📍 Nashville📍 Houston AviadoBio Ltd · Tests: Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101 Temporal Interference Stimulation Treatment in Patients With Cognitive Impairment NCT07643363NA1 site📍 Tianjin Tianjin Huanhu Hospital · Tests: Temporal Interference Stimulation, Sham Temporal Interference Stimulation, Targeted Cognitive Training, General Cogniti… Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy